Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2003
03/06/2003US20030044923 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders
03/06/2003US20030044922 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders
03/06/2003US20030044921 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044920 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044919 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders
03/06/2003US20030044918 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044917 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044916 Also stimulating the proliferation or differentiation of chondrocyte cells by contacting said cells with a PRO6029 polypeptide
03/06/2003US20030044915 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
03/06/2003US20030044914 Methods employing XOR-6, a vitamin D-like receptor from xenopus
03/06/2003US20030044913 Extracellular matrix and cell adhesion molecules
03/06/2003US20030044912 KCNQ potassium channels and methods of modulating same
03/06/2003US20030044911 Nucleotide sequences coding polypeptide for use in the treatment tumors, nervous system and cardiovascular disorders
03/06/2003US20030044910 Nucleotide sequences coding membrane protein for use in the treatment and prevention of viral and tumor diseases
03/06/2003US20030044909 Modulator of melatonin binding for use in the treatment of circadian rythm disorders
03/06/2003US20030044907 Nucleotide sequences coding polypeptide for use in the treatment and prevention of infections, gastrointestinal and inflammatory disorders
03/06/2003US20030044906 Nucleic acids, proteins, and processes for producing proteins such as fusion proteins for the secretion of a protein of interest into bacterial supernatants
03/06/2003US20030044905 Nucleic acids, proteins, and antibodies
03/06/2003US20030044904 Nucleotide sequences coding polypeptides for use in the treatment of blood, tumor and urogenital disorders
03/06/2003US20030044902 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of skin and tumor disorders
03/06/2003US20030044901 Polypeptide for use in animal models associated with human therapeutics
03/06/2003US20030044899 Isolated laminin 10
03/06/2003US20030044898 Nucleotide sequences coding polypeptide for use in the treatment of asthma, parkinson's, heart defects, hypotension, urogenital and bone disorders
03/06/2003US20030044897 Novel secreted polypeptide and methods of treatment of bone disorders
03/06/2003US20030044896 Generation of enzyme sensitie polypeptde; obtain mutant yeast cell, transform with vector coding enzyme sensitive polypeptide, express vector and polypeptide, isolate polypeptide
03/06/2003US20030044895 Nucleotide sequences coding polypeptide for use in t he treatment of tumors, respiratory and liver disorders
03/06/2003US20030044893 Nectin polypeptides, polynucleotides, methods of making and use thereof
03/06/2003US20030044892 Novel human G-protein coupled receptor, HGPRBMY6, expressed highly in small intestine
03/06/2003US20030044891 Nucleotide sequences coding mutant protein for use in generation of vaccine which prevents bordetella infections
03/06/2003US20030044890 Nucleotide sequences coding polypeptide for use in the treatment of Alzheimer's disease and brain disorders
03/06/2003US20030044889 Human HAC3
03/06/2003US20030044888 Polypeptide for use in the treatment of addison's disease
03/06/2003US20030044887 Neurogenin
03/06/2003US20030044875 Substrate for PP2C
03/06/2003US20030044867 Receptor for a bacillus thuringiensis toxin
03/06/2003US20030044863 Diagnosing cancer in humans; obtain tissue sample, detect invasive complexes associated tissus, evaluate for cancer
03/06/2003US20030044859 Reagents and methods useful for detecting diseases of the breast
03/06/2003US20030044857 Process for the preparation of a mucosal form of the eosinophil cationic protein (ECP), mucosal ECP and uses thereof as allergic phlogosis marker
03/06/2003US20030044851 Secreted protein HCEJQ69
03/06/2003US20030044844 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044842 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044841 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders
03/06/2003US20030044839 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044834 GDU, a novel signalling protein
03/06/2003US20030044828 Progressive elevated gene-3 (PEG-3) induces aggressive cancer phenotype and regulates angiogenesis
03/06/2003US20030044816 Characterization of individual polymer molecules based on monomer-interface interactions
03/06/2003US20030044815 Nucleotide sequences coding polypeptide for use in the diagnosis and classification of cancer
03/06/2003US20030044814 Diagnosing cancer in humans; obtain tissue, detect presence of marker polypeptide, monitor concentration, amplified concentration of marke protein indicates cancer
03/06/2003US20030044813 Diagnosing cancer in humans; obtain tissue, incubate with marker agent, detect signal, evaluate for cancer
03/06/2003US20030044812 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of cancer
03/06/2003US20030044809 Detection of preferential transcription factor; obtain library, screen with probe, detect hybridization, recover clone, monitor transcriptional activity of protein codes in cloned nucleotide sequences
03/06/2003US20030044807 Rhodococcus cloning and expression vectors
03/06/2003US20030044806 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003US20030044803 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of lymphoma and leukemia
03/06/2003US20030044795 Detection of preferential protein in sample; obtain sample containing preferential protein, incubate wiith solid support, expose to electric current, monitor migration, evaluate for cancer and autoimmune diseases
03/06/2003US20030044793 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders
03/06/2003US20030044792 Methods and materials relataing to novel stem cell growth factor-like polypeptides and polynucleotides
03/06/2003US20030044783 Human genes and gene expression products
03/06/2003US20030044774 Epitope sequence for use as tool in diagnostic analysis
03/06/2003US20030044431 Over-expressing homologous antigen vaccine and a method of making the same
03/06/2003US20030044430 Pertussis toxin gene: cloning and expression of protective antigen
03/06/2003US20030044429 Immunomodulatory flagellin peptide having at least about 10 amino acids; immunotherapy treatment of cancer
03/06/2003US20030044427 Compositions and methods for treating Papillomavirus-infected cells
03/06/2003US20030044426 Attenuated pestiviruses
03/06/2003US20030044423 Particularly relates to antibodies and fusion proteins in which a hinge region derives from one isotype and the CH2 domain derives from a different isotype
03/06/2003US20030044422 Ehrlichia ruminantium polypeptides, antigens, polynucleotides, and methods of use
03/06/2003US20030044421 Adenoviral vaccines when administered alone or in combined modality regime offer prophylactic advantage to previously uninfected individuals and/or provide therapeutic effect by reducing viral load levels within infected individual
03/06/2003US20030044419 Use of reagents derived from nucleic acid and amino acid sequences of Int6 gene in diagnostic methods, immunotherapy, gene therapy and as vaccines
03/06/2003US20030044418 Use of SdrG, a fibrinogen-binding bacterial adhesin or its binding region as an anti-coagulation agent by virtue of its ability to inhibit thrombin-induced fibrin clot formation by interfering with release of fibrinopeptide B
03/06/2003US20030044416 Nucleic acids encoding cd100 molecules
03/06/2003US20030044415 Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means
03/06/2003US20030044409 Complexing to epitope; cancer immunotherapy
03/06/2003US20030044405 Sustained release; drug delivery; tissue adhesive
03/06/2003US20030044404 Regulation of angiogenesis with zinc finger proteins
03/06/2003US20030044386 Genetic engineering; nucleic acid coding cytokines
03/06/2003US20030044383 Tissue specific adenoviral vectors
03/06/2003US20030043176 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/06/2003CA2496180A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003CA2459183A1 Amplified oncogenes and their involvement in cancer
03/06/2003CA2458924A1 Casein derived peptides and uses thereof in therapy
03/06/2003CA2458866A1 Compositions and methods of treating diabetes
03/06/2003CA2458849A1 Obesity related genes expressed at least in the hypothalamus, liver or pancreas
03/06/2003CA2458627A1 Human cdr-grafted antibody and antibody fragment thereof
03/06/2003CA2458622A1 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
03/06/2003CA2458574A1 Reagents and methods for smooth muscle therapies
03/06/2003CA2458565A1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain
03/06/2003CA2458561A1 Yeast membrane protein expression system and its application in drug screening
03/06/2003CA2458559A1 Gene of novel corynebacterium diphtheriae antigen
03/06/2003CA2458445A1 Extracellular messengers
03/06/2003CA2458381A1 Transmembrane protein differentially expressed in cancer
03/06/2003CA2458371A1 Glucagon-like peptide-1 analogs
03/06/2003CA2458236A1 Gpi-anchored cytokines
03/06/2003CA2458202A1 Estrogen receptor alpha variants and methods of detection thereof
03/06/2003CA2457903A1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003CA2457890A1 Vaccine using papillomavirus e proteins delivered by viral vector
03/06/2003CA2457885A1 Antimicrobial and anti-inflammatory peptides
03/06/2003CA2457879A1 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003CA2457779A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
03/06/2003CA2457502A1 Gamma three protease
03/06/2003CA2457488A1 Antimicrobial agent
1 ... 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 ... 2916